The partnership builds on Sientra’s safety profile by empowering surgeons with Butterfly Network’s cutting-edge point-of-care ultrasound technology to screen and...
SAN FRANCISCO and SAN DIEGO, April 30, 2021 (GLOBE NEWSWIRE) -- Kinnate Biopharma Inc. (Nasdaq: KNTE) (“Kinnate”), a biopharmaceutical company...
Conference Call and Webcast Scheduled for May 6, 2021, 4:30 p.m. Eastern TimePRINCETON, N.J., April 30, 2021 (GLOBE NEWSWIRE) --...
SAN JOSE, Calif., April 30, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”)...
NEW YORK, April 30, 2021 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (the “Company” or “BeyondSpring”) (Nasdaq: BYSI), a global biopharmaceutical company...
Press release FINANCIERE DE TUBIZE SA/NV Allée de la Recherche 60, 1070 Brussels Contact: Eric Nys, general manager, eric.nys@financiere-tubize.be Approval...
Study to be Conducted at The University of Texas MD Anderson Cancer CenterLONDON and REDWOOD CITY, Calif. and HOUSTON, Texas,...
TORONTO, April 30, 2021 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (the “Company” or “Acerus”) (TSX:ASP; OTCQB:ASPCF) today announced that it...
FORT LAUDERDALE, Fla., April 30, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"),...
BEIJING, April 30, 2021 (GLOBE NEWSWIRE) -- So-Young International Inc. (Nasdaq: SY) (“So-Young” or the “Company”), the largest and most...
EMERYVILLE, Calif., April 30, 2021 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT), a clinical-stage gene therapy company harnessing the...
Kraig Labs honors its commitment to eco-responsible Spider Silk production with significant expansion of tree plantingANN ARBOR, Mich., April 30,...
SOUTH SAN FRANCISCO, Calif., April 30, 2021 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage biotechnology company focused...
Reports first quarter 2021 revenue of $9.2 million, GAAP diluted EPS of $0.11 and non-GAAP diluted EPS of $0.13Reports combined...
Press release Synairgen plc(‘Synairgen’ or the ‘Company’) Synairgen announces data from Home Cohort of SG016 Phase II trial of inhaled...
IP portfolio now totals over 160 patents issued, allowed, and pendingSALT LAKE CITY, April 30, 2021 (GLOBE NEWSWIRE) -- Clene...
NEW YORK and MAINZ, GERMANY, April 30, 2021 (GLOBE NEWSWIRE) — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX)...
- NDAs filed in the U.S. and China in Mar. 2021 based on superior data from Phase 3 PROTECTIVE-2 trial...
82 Patient Pivotal cohort expected to commence in second half of 2021 BEDMINSTER, N.J. and SINGAPORE, April 30, 2021 (GLOBE...
Dividend amount: NOK 0.5 Declared currency: NOK Last day including right: 20 May 2021 Ex-date: 21 May 2021 Record date:...